|
|
||||||||
Ann Thorac Surg 1994;58:851-856
© 1994 The Society of Thoracic Surgeons
Divisions of Cardiothoracic Surgery and Adult Cardiology, Medical University of South Carolina, Charleston, South Carolina USA
Accepted for publication February 8, 1994.
* Address reprint requests to Dr Walker, Division of Cardiothoracic Surgery, Medical University of South Carolina, 171 Ashley Ave, Charleston, SC 29425.
Recent studies have suggested that acute administration of 3, 5, 3' triiodo-L-thyroninc (T3) may increase ventricular performance; however, the direct cellular effects of acute T3 administration are not understood. The objectives of this study were to determine (1) whether T3 acts directly on the cardiac muscle cell (myocyte) itself, and (2) whether T3 acts independently of the myocyte β-adrenergic receptor. Accordingly, isolated myocyte function was examined using video-microscopy in normal porcine myocytes (n = 60) in the control state and in the presence of increasing T3 concentrations (10 to 500 pmol/L). T3 caused myocyte shortening extent, shortening velocity, and lengthening velocity to increase in a dose-dependent manner. For example, shortening velocity increased from 49.2 ± 4.3 µm/s at baseline to 66.5 ± 6.1 µm/s with 100 pmol/L T3 (p < 0.05). β-Adrenergic stimulation with 25 nmol/L isoproterenol increased shortening velocity to 97.6 ± 5.7 µm/s; isoproterenol with T3 increased shortening velocity further to 168.5 ± 10.9 µm/s. Analysis of variance revealed that this increase with T3 was independent of and additive to the β-adrenergic receptor system. In summary, T3 caused a dose-dependent increase in myocyte contractile performance, and these effects were independent of and additive to β-adrenergic receptor stimulation. Thus, acute T3 administration may provide a novel modality to improve left ventricular contractile function independent of the β-adrenergic receptor system.
This article has been cited by other articles:
![]() |
E Mezosi, J Szabo, E V Nagy, A Borbely, E Varga, G Paragh, and Z Varga Nongenomic effect of thyroid hormone on free-radical production in human polymorphonuclear leukocytes J. Endocrinol., April 1, 2005; 185(1): 121 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Carrel, F. Eckstein, L. Englberger, R. Mury, and P. Mohacsi Thyronin treatment in adult and pediatric heart surgery: clinical experience and review of the literature Eur J Heart Fail, October 1, 2002; 4(5): 577 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Sun, K. Ojamaa, W. A. Coetzee, M. Artman, and I. Klein Effects of thyroid hormone on action potential and repolarizing currents in rat ventricular myocytes Am J Physiol Endocrinol Metab, February 1, 2000; 278(2): E302 - E307. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Walker, F. A. Crawford Jr., R. Mukherjee, and F. G. Spinale THE DIRECT EFFECTS OF 3,5,3'-TRIIODO-L-THYRONINE (T3) ON MYOCYTE CONTRACTILE PROCESSES: Insights into mechanisms of action J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1369 - 1380. [Abstract] [Full Text] |
||||
![]() |
J. D. Walker, F. A. Crawford Jr, and F. G. Spinale 3,5,3' triiodo-L-thyronine pretreatment with cardioplegic arrest and chronic left ventricular dysfunction Ann. Thorac. Surg., August 1, 1995; 60(2): 292 - 299. [Abstract] [PDF] |
||||
![]() |
J. D. Walker, F. A. Crawford, and F. G. Spinale PRETREATMENT WITH 3,5,3' TRIIODO-L-THYRONINE (T3): Effects on myocyte contractile function after hypothermic cardioplegic arrest and rewarming J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 315 - 327. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |